LENSAR, Inc.

NasdaqCM LNSR

LENSAR, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -34.03%

LENSAR, Inc. Net Income Margin is -34.03% for the Trailing 12 Months (TTM) ending September 30, 2024, a 0.91% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

LENSAR, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -34.34%, a 41.09% change year over year.
LENSAR, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -58.29%, a 18.44% change year over year.
LENSAR, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -71.47%, a -23.14% change year over year.
LENSAR, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -58.04%.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

NasdaqCM: LNSR

LENSAR, Inc.

CEO	Mr. Nicholas T. Curtis
IPO Date	Oct. 2, 2020
Location	United States
Headquarters	2800 Discovery Drive
Employees	130
Sector	Consumer Discretionary
Industries Eyewear Augmented Reality (AR) Cosmetics

Description

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Key trends

Past 5 years